|Market Research A to Z | Company Profiles A to Z | Register | Contact Us | Shopping Basket|
|+44 (0) 203 086 8600 Call us on|
During 2011 the microRNA research tools market reached a global value $295.3 million. This year (2012), the market is expected to have continued on its growth trajectory with a value expected to total $338.3 million. Over the longer the term the market is suggested the keep up the momentum, and reach a high of $736 million by 2017. Worked out as a CAGR percentage, the microRNA research tools market will have grown at a CAGR of 17.7% between 2012 and 2017.
The microRNA research tools market can be broken down into a number of specific sectors. The largest of these sectors is the tools and reagents sector, which will hit a value of $640 million by 2017, after reaching $278 million during 2012. The therapeutics sector of microRNA will reach $120 million by 2017, after gaining a value of $60 million in 2012.
RNA represents one of the three major macromolecules (along with DNA and proteins) essential for cell function. Similar to DNA, RNA consists of a long chain of nucleotides when the sequence of these molecules encodes genetic information. The main difference between the DNA and RNA sequence is the nucleobase uracil in the RNA sequence, while DNA contains thymine (a methylated form of uracil). In addition, unlike DNA, most RNA molecules are single-stranded. Consequently, single-stranded RNA can adopt very complex, three-dimensional structures essential for the proper function and regulation of cellular processes.
The microRNA phenomenon was discovered in the early 1990s. Yet only now scientists and industry insiders are recognizing the importance of this discovery.
The microRNA biogenesis process is essentially the basis for current RNA interference drug discovery and therapeutics research. It led to the development of a very important experimental approach of gene silencing by synthetic double stranded RNA molecules. Today, siRNA tools are among the routine laboratory techniques and essential requirements for scientific proof of concept. Moreover, scientists came to realize that the microRNA silencing pathway is efficient in downregulation of number of target genes, which makes it better in terms of therapeutics development. More importantly, the microRNA expression profile represents critical signatures for biomarker and diagnostic product development.
These facts force diagnostics and therapeutics companies to reconsider microRNA space and to look more closely into microRNA research, diagnostics and therapeutics product development.
Although microRNAs are part of the RNA research market in general, the microRNA sector exhibits specific characteristics and differences in its market participants and competitive landscape.
This report highlights the main segments in the microRNA market: reagents and tools essential for research, current diagnostics products and their development, and drug candidates in the pipelines of different companies. This report also discusses major players, current and future trends, and influences. Drivers and challenges in each segment of this industry are described in detail, including forecasts for the next five years.
This report, MicroRNA Diagnostics and Therapeutics: Technologies and Global Markets, provides an overview of the current state of the microRNA market, focusing specifically on tools, reagents, techniques, diagnostics and therapeutics products. It describes products and tests currently on the market and a detailed analysis of the competitive environments, including new potential trends and markets for novel products and assay development. This study includes information about significant players, trends, and obstacles and other information affecting this market and its different sectors.
Free Research Support: Let us do the work for you and find information from public and private sources of information. Contact us now and we can save you time and money.......Free Research Support
For the last month in 2014 we are offering discounted prices on a selection of new reports. Please contact us on 00 44 (0) 203 0868600 or via email (click here to email) to ask about prices and special discounts.
Available during December and the run-up to Christmas; Discounted prices on a selection of our reports.
We are offering our clients substantial savings on the best research available during December. Please contact us either via emailor by calling our team to discuss your specific research needs on Tel: 00 44 (0) 203 0868600. We look forward to being able to find you the research you require at good prices.